Streamline Health Solutions (STRM) Q1 2026 earnings summary

Executive summary

• Entered into a definitive merger agreement with Mist Holding Co./MDaudit; shareholders to receive $5.34 per share in cash, a 138% premium, upon closing, subject to customary conditions and approvals.

• SaaS revenue grew 23% year-over-year, offsetting declines in maintenance and support; total revenue up 11–12% to $4.8 million for the quarter ended April 30, 2025.

• Net loss narrowed to $1.6–$1.65 million from $2.7–$2.74 million year-over-year; Adjusted EBITDA turned positive at $0.2–$0.226 million versus a loss of $0.7 million in the prior year.

• Company faces substantial doubt about its ability to continue as a going concern due to liquidity constraints and forecasted covenant non-compliance.

• Material weaknesses in internal controls over financial reporting remain unresolved as of April 30, 2025.

Financial highlights

• Total revenue increased 11–12% year-over-year to $4.8 million, driven by SaaS growth.

• SaaS revenue: $3.4 million, up 23% year-over-year, now 70% of total revenue.

• Net loss improved to $1.6–$1.65 million from $2.7–$2.74 million year-over-year.

• Adjusted EBITDA was $0.2–$0.226 million (5% margin), up from negative $0.7 million (-16% margin) in the prior year.

• Cash and cash equivalents decreased to $1.4–$1.45 million from $2.18–$2.2 million at prior fiscal year-end.

Outlook and guidance

• SaaS revenue expected to remain flat for the remainder of fiscal 2025; maintenance and support revenue anticipated to decline due to contract non-renewals.

• Merger with MDaudit expected to close in Q3 2025, with shareholders to receive $5.34 per share.

• Company expects continued cost-saving measures and focus on flagship SaaS products.

• Management projects probable non-compliance with certain financial covenants in the next 12 months, raising going concern risks.